期刊文献+

1例肾移植术后重症肺炎患者的药学监护 被引量:4

暂未订购
导出
摘要 肾移植患者长期服用免疫抑制药,免疫功能低下,易并发各种感染、治疗过程中,既要有效控制复杂感染,又要兼顾其移植物功能。众多实践证实,临床药师对患者进行药物监护,有助于此类患者的预后。现将参与1例肾移植术后重症肺炎治疗的用药监护过程报道如下。1病例摘要患者,男,54岁,2012年3月19日因"咳嗽咳痰伴发热、呼吸困难4 d"入院。患者2001年前于九江市某医院行"同种异体肾移植术",目前口服他克莫司1 mg,bid,有"肾性贫血"、"痛风"、"慢性胆囊炎"病史多年,4 d前无明显诱因出现咳嗽,咳痰,偶伴有呼吸困难,以活动后明显,伴有发热,
出处 《中国药师》 CAS 2013年第7期1066-1067,共2页 China Pharmacist
  • 相关文献

参考文献5

二级参考文献20

  • 1许长宝,夏熙正,郝斌,何朝红,朱国鸿,吴国清.肾移植术后不明病原体肺部感染糖皮质激素治疗体会[J].郑州大学学报(医学版),2005,40(5):939-940. 被引量:18
  • 2毛允义,李新长,孟栋良,熊焕腾,曾涛.免疫抑制剂在肾移植术后肺部感染中的应用[J].江西医学院学报,2006,46(4):158-159. 被引量:5
  • 3Linhares MM,Gonzalez AMNrivino TV,et al.Simultaneous pancreas -kidney transplantation:infeetiouseomplications and microbiological aspects.Transplant Proe,2004,36(4):9801.
  • 4张象麟,主编.药物临床信息参考.第3版.成都:四川科学技术出版社.267.
  • 5Chisholm MA,Vollenweider LJ,Mulloy LL,et al. Direct patient care services provided by a pharmacist on a multidisciplinary renal transplant team[J]. Am J Health-syst Pharm,2000,57: 1599.
  • 6Chisholm MA,Mulloy LL,Jagadeesan M,et al. Impact of clinical pharmacy services on renal transplant patients' compliance with immunosuppressive medications[J]. Clin Transplant,2001,15(5):330.
  • 7Didlake RH,Dreyfus K,Keran RH,et al. Patient noncompliance: a major cause of late graft failure in cyclosporine-treated renal transplants[J]. Transplant Proc,1998,20 (suppl 3): 63.
  • 8Vasquez EM,Tanzi M,Benedetti E,et al. Medication noncompliance after kidney transplantation[J]. Am J Health-syst Pharm,2003,60: 266.
  • 9Schwinghammer TL. Pharmacotherapy Casebook [ M] . Sixth edition. United States: McGraw- Hill, MedicalPublishing Division,2005: 1.
  • 10McCallian DJ, Carlstedt BC, Rupp MT. Elements of a pharmaceutical care plan[J ]. Am J Pharm Assoc, 1999, 39(1) : 82.

共引文献30

同被引文献53

  • 1谭永红,曾仁杰,王诗华,段艳冰,梁蓉梅.临床药师应重视肿瘤患者的药疗监护[J].中国药房,2004,15(12):763-764. 被引量:18
  • 2余自成,蔡卫民,王祥慧,徐达.肾移植病人的药学监护[J].中国医院药学杂志,2005,25(3):276-276. 被引量:7
  • 3汪复,张婴元.实用抗感染治疗学[M].北京:人民卫生出版社,2005:134.
  • 4Rubin RH, Wo|fson JS, Cosimi AB,et al. Infection in the re- nal transplant [ J ]. Am J Med, 1981,70 ( 1 ) :405-411.
  • 5Charfeddine K, Zaghden S, Kharrant M, et al. Infectious complica-tions in kidney transplant recipients : a single-center experience [ J ].Transplant Proc,2005, 37(6) : 2823-2825.
  • 6Green M. Introduction : Infections in Solid Organ Transplantation[J ]. Am Joural of Transplantation, 2013, 13: 3-8.
  • 7Sagedal S,Hartmann A,Nordal KP, et al. Impact of early cytomega-lovirus infection disease on long-term recipient and kidney graft sur-vival [J]. Kidney Int, 2004,66(1) : 329-337.
  • 8Blackwell M. Immunosuppressive drug interaction with anti-infectiveagents[ J]. Am J Transplant,2004 , 4: 164-166.
  • 9Thomas LD,Miller GG. Interactions between anti-infective agentsandimmunesuppressants [ J ]. Am J Transplant, 2009, 9: S263-266.
  • 10Chisholm MA, Lance CE, Mulloy LL. Patient factors associated withadherence toimmunosuppressant therapy in renal transplant recipients[J]. Am J Health Syst Pharm, 2005,62( 17) : 1775-1778.

引证文献4

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部